trial · primary record
lerodalcibep
Heterozygous Familial Hypercholesterolemia
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 478 |
| Primary completion | 2023-12-05 |
| Primary endpoint | Change From Baseline Compared to Placebo in LDL-C Level Calculated by Friedwald Formula at Week 24 |
| Registry ID | NCT04797104 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:41.826Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04797104
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.